MATRIX TABLET LOOKING TO PROLONGATE THE OUTLET OF GLYCLLAZIDE AFTER ORAL RECEPTION

摘要

The invention relates to a matrix tablet for a prolonged release of gliclazide, which provides a long and stable yield of the active substance prescribed for oral administration, and eliminates the dependence of the output on the pH of the solvent medium. The international application was published along with an international search report.